A clinical trial investigating the effectiveness of a new tuberculosis regimen in Indian patients is halfway through enrollment. The data safety monitoring board (DSMB) has identified a significant imbalance in baseline characteristics between the intervention and control groups despite randomization. Which investigation/procedure is most appropriate to assess whether this imbalance could have occurred by chance alone?